Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How will PDS pay TPL

Pursuant to the settlement agreement (taken from 10Q)

3) we have agreed to have PDS pay TPL for certain litigation and reexamination support services at the rate of $172,000 for June 2011, and $86,000 per month thereafter until 60 days after the Markman hearing in the current patent infringement litigation,

p.21

With respect to PDS and TPL, we do not have any contractual commitments and do not intend to fund any cash requirements of these entities.

On October 7, 2011 PDS’ cash balance is $79,130. Management’s plans for the continued operation of PDS rely on the ability of TPL to obtain license agreements to cover the operational costs of PDS. (emphasis by me)

p.23

If PTSC does not intend to fund any cash requirements of PDS or TPL, and PDS is supposed to pay TPL as agreed.....where is the money coming from? Can we expect license announcements next week? Let's hope so.

Share
New Message
Please login to post a reply